- By Marcy Richardson, PhD
- Posted December 19, 2023
The Path to Clinical Relevance: What a Study on RAD51C Reveals about Resolving VUS
Everyone has genetic variation….and lots of it. It’s part of what makes us each unique. Genetic variation is defined by differences in our own genome and a reference genome. (The fact that there is only one reference genome selected to compare to all of our collective, rich, human diversity is a topic for another post.) Another source of genetic…
- By Deepti Babu, MS, CGC
- Posted April 14, 2017
Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer
New clinical evidence collected from >65,000 women with breast cancer demonstrates 83% of positive test results are found in genes that impact clinical management Multi-gene germline genetic testing allows for efficient analysis, maximizing risk assessment while minimizing the time needed for results. This has been particularly effective…
- By Jackie Connor
- Posted February 6, 2017
Genetic Testing Accuracy Explained During the AmbrySpeaks-Los Angeles Event
In the first of seven dinner series events, on Tuesday, January 31st, Ambry Genetics presented to more than 45 attendees at Spago in Beverly Hills, California. The “AmbrySpeaks Tour—Accuracy and Innovation in the Era of Collaborative Genetics” challenges the common misconception that Next-generation sequencing (NGS) is 100 percent accurate,…
- By Deepti Babu, MS, CGC
- Posted December 23, 2016
New Research on Male Breast Cancer: Unexpected Results and Insights
Breast cancer in men may be rare in the average population, but is far more common in people with an underlying genetic predisposition. Finding a cancer gene mutation in a man with breast cancer can drastically impact medical management for him and his family members (who may otherwise not be screened for the disease). Current guidelines recommend…